This report outlines key trends shaping how life sciences companies are adopting and using Veeva platforms. It focuses on demand-side developments that influence the use of tools across Veeva’s ecosystem, including clinical, regulatory, quality, and commercial functions. The report also highlights common challenges enterprises face in implementing and scaling Veeva solutions, based on Avasant’s analysis of provider capabilities and client experiences.

Why read this Market Insights?

This report provides insights into how the life sciences industry is adopting Veeva platforms in response to growing investments in technologies such as generative AI, advanced analytics, automation, and cybersecurity. It examines how companies are using Veeva solutions to improve R&D efficiency for faster treatment development, supporting personalized medicine through better data and process integration, and strengthening manufacturing and supply chains for more reliable delivery of therapies. The report also looks at how Veeva’s commercial tools are helping organizations enhance customer engagement and streamline market access. It offers a clear view of how service providers are supporting these efforts and where challenges remain in implementing and scaling Veeva solutions.

The Veeva Services 2025 Market Insights™ aids enterprises in this sector in identifying important market trends and challenges for any digital project they participate in.

Methodology

The industry insights presented in this report are based on our ongoing interactions with enterprise CXOs and other key executives; targeted discussions with service providers, subject matter experts, and Avasant Fellows; analyst insights from primary and secondary research; and lessons learned from consulting engagements.

Table of contents

About the report (Page 3)

Executive summary (Pages 4–7)

• • Scope of coverage
  • Key market drivers and enterprise response
  • Avasant recognizes 11 top-tier Veeva service providers supporting the digital transformation of life sciences enterprises

Demand-side trends (Pages 8–12)

• • Life sciences companies are adopting cloud-based clinical platforms to centralize trial management, streamline data, and replace legacy systems, thus accelerating trial startup, enhancing collaboration, and improving compliance across teams
  • Life sciences firms are enhancing commercial strategies by integrating digital health tools, telehealth, and AI-driven engagement to offer personalized experiences to patients and healthcare personnel
  • Enterprises are using automation and cloud-based systems to improve quality and safety monitoring and enable real-time decision-making
  • Life sciences companies are using cloud-based RIM systems to centralize regulatory operations, ensure compliance, and streamline submissions through consistent data management and efficient collaboration

Key contacts (Page 13)

Read the Research Byte based on this report. Please refer to Avasant’s Veeva Services 2025 RadarView™ for detailed insights on the service providers and supply-side trends.